Valeo Pharma Inc (VPH.TO)
0.095
-0.01
(-9.52%)
CAD |
TSX |
May 06, 13:12
Valeo Pharma Cash from Investing (TTM): -5.152M for Jan. 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| January 31, 2024 | -5.152M |
| October 31, 2023 | -5.553M |
| July 31, 2023 | 4.433M |
| April 30, 2023 | -7.015M |
| January 31, 2023 | -6.91M |
| October 31, 2022 | -6.891M |
| July 31, 2022 | -13.01M |
| April 30, 2022 | -1.564M |
| January 31, 2022 | -3.506M |
| October 31, 2021 | -3.465M |
| July 31, 2021 | -2.752M |
| Date | Value |
|---|---|
| April 30, 2021 | -3.241M |
| January 31, 2021 | -1.336M |
| October 31, 2020 | -1.405M |
| July 31, 2020 | -1.165M |
| April 30, 2020 | -1.154M |
| January 31, 2020 | -0.989M |
| October 31, 2019 | -0.923M |
| July 31, 2019 | -0.706M |
| April 30, 2019 | 0.221M |
| January 31, 2019 | -0.0208M |
| October 31, 2018 | 0.063M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-13.01M
Minimum
Jul 2022
4.433M
Maximum
Jul 2023
-3.279M
Average
-2.752M
Median
Jul 2021